MedPath

SUTURE-CLOSURE OMENTOPEXY VERSUS OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER

Not Applicable
Recruiting
Conditions
Perforated Peptic Ulcer
Registration Number
NCT06550856
Lead Sponsor
Sohag University
Brief Summary

The present study will be conducted to assess whether there is a direct benefit associated with modified-Graham's omentopexy (MGO), above and beyond the benefit associated with Graham's omentopexy (GO) in the treatment of perforated duodenal ulcers. We attempted to answer the question whether primary closure of the perforation in MGO will affect the outcome of surgery. Complication rates will be compared for the two alternative surgical procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • All adult patients of both sexes with a clinical diagnosis of perforated peptic ulcer (gastric or duodenal) that are fit to undergo surgery.
Exclusion Criteria
    1. Patients with associated bleeding ulcer (additional steps are needed to control bleeding).
  1. Patients with associated pathology other than perforated peptic ulcer that needs surgical intervention.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Early postoperative follow up for repair of perforated peptic ulcerThree days after the operation

resumption of oral intake

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag university Hospital

🇪🇬

Sohag, Egypt

Sohag university Hospital
🇪🇬Sohag, Egypt
Magdy M Amin, Professor
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.